Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹126.2 Cr -3.9% -18.3% -67.4% Stock Analytics
ADANI ENTERPRISES ₹287,822.0 Cr 11.6% -2.1% 1.7% Stock Analytics
REDINGTON ₹20,994.6 Cr -0% -5.6% 31.1% Stock Analytics
MMTC ₹9,603.0 Cr 2% -5.9% -6.6% Stock Analytics
HONASA CONSUMER ₹9,279.6 Cr 3.6% -5% 22.8% Stock Analytics
LLOYDS ENTERPRISES ₹9,147.1 Cr 4.2% -10.5% 25.7% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-3.9%

-18.3%

-67.4%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses